Procyanidin C1 dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Procyanidin C1 is a grape seed compound that a 2021 paper said kills worn-out cells and helps old mice live longer. Since March 2026 the journal has flagged that paper with a formal warning. There is no proof in people for the pure compound.
Evidence grade for Procyanidin C1: Animal or lab only. The rule: only animal or lab studies on this page. No study in people yet. The sum on this page: 2 animal studies, no human study. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 0
- Found nothing
- 0
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
2 animal studies, no human study
2 effects reported, 2 unwanted, by people using it, not a trial
Goal pages: Ageing and longevity, Heart and circulation
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
Procyanidin C1 is a compound in grape seed extract. A 2021 mouse paper said it kills worn-out cells and helps old mice live longer. In 2026 the journal put a formal warning on that paper. The pure compound is a lab chemical.
What people take it for
- Living longer.
- Clearing worn-out cells.
- An excuse to take grape seed extract.
What studies in people showed
Nobody has tested the pure compound in people. There is no study in people, and none is registered. Since nobody can patent grape seed, nobody is likely to pay for one. In mice, one 2021 paper said old mice lived longer. The journal flagged that paper in March 2026 and gave no reason. Two other mouse studies found it helped ageing eyes and scarred kidneys.
What people report
Reports, not study results
The good
- We have not collected user reports on this one yet.
The bad
- The main paper behind the lifespan claim now carries a formal warning from its journal.
- Nobody knows what blood level a grape seed supplement gives you.
Where these come from: The points above are from the papers on this page. There are no studies in people and we have no forum reports.
My bottom line
The lifespan claim rests on one mouse paper that its own journal has flagged. Eat grapes if you like them. Do not buy the story.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Animal and lab work, not yet tested in people
Real results, but from animals or cells, not people. What works in a mouse often does not work the same way in a person. Nobody can patent this, so nobody would ever earn back the cost of a study in people. That is usually why there is none. The record on this one is set out below.
- Eyes and vision1 animal or lab study
- Living longer1 animal or lab study
- Kidney function1 animal or lab study
33 of the 36 indexed goals have no study of any kind behind Procyanidin C1
No study in people, animals or cells on this page reports a result for these. That does not prove Procyanidin C1 does nothing for them. It does mean anything you have heard about Procyanidin C1 and one of these did not come from a study cited here.
Show full evidence
What is Procyanidin C1?
Procyanidin C1 is a grape seed compound that a 2021 paper said kills worn-out cells and helps old mice live longer. Since March 2026 the journal has flagged that paper with a formal warning. There is no proof in people for the pure compound.
Procyanidin C1 is a plant compound found in grape seed extract.
Nobody has been given the pure compound in a published study. There is no study in people, no study of how the body handles it, and none registered. No clean-up drug has improved health in a proper study in people.
In mice, a 2021 paper in Nature Metabolism put it on the map. It said the compound did two things depending on the amount. At low amounts it calmed the harmful signals worn-out cells give off. At higher amounts it killed worn-out cells. Given now and then to old mice, it eased physical decline and helped them live longer.
In March 2026, the journal published a formal Expression of Concern about that paper. We checked the notice. It points to the 2021 paper but gives no reason, so we cannot say what the concern is. It is not a retraction, and it does not mean the results are wrong. It is the journal telling readers not to rely on the paper while it looks into things. The claim that it helps mice live longer rests on that one paper.
Other groups have used it in mice too. It eased age-related decline in the eyes of old mice, and cut kidney scarring after a blocked kidney. Both are mouse studies, and neither looked at lifespan.
How does Procyanidin C1 work?
Reported in cells and in mice: at low amounts, procyanidin C1 calms the harmful signals worn-out cells give off. At higher amounts, it makes worn-out cells die. That split by amount is the main claim, and it comes from the paper now flagged by the journal. Nothing has been checked in people.
What have studies in people found about Procyanidin C1?
None. Nobody has been given the pure compound in a published study, there is no data on how the body handles it, and no study is registered.
What this does not tell you: With no dosing data in people, there is no way to know what blood level a grape seed supplement gives, or whether it gets anywhere near the levels used in mice. The mouse work depends on a split: calming at low amounts, killing at higher amounts. That split means nothing without knowing where a human dose lands.
The state of the research
The status of the main paper is the most important fact on this page. In March 2026 the journal flagged the 2021 lifespan paper with an Expression of Concern. Nobody else has repeated the mouse lifespan result. Procyanidin C1 should not be called a proven clean-up drug while that stands.
The two later mouse papers, on eyes and kidneys, used it as a clean-up tool and found effects in those organs. They did not test lifespan, and they do not settle the concern about the 2021 paper. Grape seed extract is a plant product nobody can patent. So no company has a business reason to pay for studies in people, and none are registered. That explains the empty record in people. It is not a reason to assume a good result is waiting to be found.
The evidence, in charts
Fig. 1a · how many people
0people have taken this in any study cited here
0 people · 0 studies in people
What this page cites instead is 3 animal studies and 1 review. None of them gave the compound to a person.
Counted from the list of sources on this page. We draw this chart only when a study in people is cited. An empty one is the answer, not a gap in the page.
Fig. 1b · evidence mix
None of the 4 sources here are studies in people.
- Animal study · done in animals375%
- Review of studies · sums up other studies125%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 4 different years, 2021 to 2026, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Supplement
- Molecule weight
- Not on file
- Half-life
- None on file
- Chain length
- None on file
No amino acid sequence is on file for Procyanidin C1, which is expected: a supplement is not built from amino acids.
The studies we cite
- Review of studies2026Editorial Expression of Concern: The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice
The journal's formal warning about the 2021 paper, published in March 2026. We checked that it is live and points to the 2021 paper. It gives no reason, so we cannot say what the concern is. It is a flag, not a retraction.
Editorial Expression of Concern published March 2026, verified live and explicitly referencing the 2021 paper. The indexed record carries no explanatory text, so the specific reason cannot be established from it. This is a flag, not a retraction.
- Animal study2021
Pulled or flagged by the journalAn Editorial Expression of Concern about this paper was published in Nature Metabolism in March 2026. PubMed links the two records.
The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in miceIn mice and in a dish. At low amounts it calmed the harmful signals worn-out cells give off. At higher amounts it killed worn-out cells. Given now and then to old mice, it eased physical decline and helped them live longer. The journal flagged this paper with an Expression of Concern in March 2026.
Mouse and cultured cells. Low concentrations suppressed the senescence-associated secretory phenotype; higher concentrations killed senescent cells. Intermittent dosing of old mice alleviated physical dysfunction and prolonged survival. This paper is subject to an Editorial Expression of Concern issued in March 2026.
- Animal study2024Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina
In old mice. Long-term treatment cut worn-out cells in the eye and eased age-related decline in how the eye is built and works. Mouse only, and it did not look at lifespan.
Naturally aged mice. Long-term procyanidin C1 treatment reduced retinal senescent cell burden and ameliorated age-related structural and functional decline in the retina, characterised by single-cell RNA sequencing. Mouse, no lifespan endpoint.
- Animal study2025Senolytic procyanidin C1 alleviates renal fibrosis by promoting apoptosis of senescent renal tubular epithelial cells
In mice. After a blocked kidney, procyanidin C1 cut worn-out kidney cells and kidney scarring. Worn-out kidney cells were also seen in blocked human kidneys, but only looked at, not treated.
Mouse ureteral obstruction model, with senescent tubular cells also observed in obstructed human kidney tissue. Procyanidin C1 reduced senescent tubular cells and renal fibrosis in the mice. The human component is tissue observation, not treatment.
Common questions
Has Procyanidin C1 been tested in people?
Not in any study cited here. Procyanidin C1 is a grape seed compound that a 2021 paper said kills worn-out cells and helps old mice live longer. Since March 2026 the journal has flagged that paper with a formal warning. There is no proof in people for the pure compound.
What is the Procyanidin C1 dosage?
No human dose established. No published study on this page has given this compound to people and reported a result. 2 animal studies, no human study
Is Procyanidin C1 FDA-approved?
Not approved for any use. Not being tested in people. It is one of the ingredients in grape seed extracts sold as supplements. The pure compound is a research chemical.
Does procyanidin C1 extend lifespan?
One 2021 mouse paper said old mice lived longer. Since March 2026, the journal has flagged that paper with a formal Expression of Concern. Nobody else has repeated it. And there is no proof in people that any clean-up drug extends life.
What is an Editorial Expression of Concern?
A notice from a journal telling readers that questions have been raised about a paper, and that they should not rely on it while the questions are looked into. It is not a retraction, and it does not prove the results are wrong. In this case the notice gives no reason, so the reason cannot be checked.
Is taking grape seed extract the same as taking procyanidin C1?
No. Grape seed extract contains procyanidin C1 along with many other plant compounds, in amounts that vary by product. No study has measured what blood level of procyanidin C1 a supplement gives a person.